-
Based on a survey of research participants, the office of research compliance and quality improvement at Cedars-Sinai Medical Center in Los Angeles, CA, has come up with these four key areas to demonstrate informed consent.
-
Research institutions increasingly are turning to central IRBs for multisite clinical trials, and this trend probably will accelerate due to recent news that federal regulators are encouraging the change, experts say.
-
In this issue: Aggressive approach to CVD reduces MI, folic acid and vitamin B12 for CAD, corticosteroids for acute exacerbations of COPD, prescription drug abuse among young adults, and ARBs and cancer risk.
-
A number of reports on dengue have been published recently in the Morbidity and Mortality Weekly Report. The CDC described dengue surveillance in the United States using two sources of data: 1) specimens tested at the CDC Dengue Branch (CDCDB); and 2) the ArboNET surveillance system of the CDC Arboviral Diseases Branch.
-
-
Murray and colleagues provide a rigorous description of child mortality in 187 nations of the world.
-
A 39-year-old man had traveled for four weeks to the Pantanal region of Brazil, a popular ecotourism area, where he had walked barefoot on several occasions. Ten days before returning to the UK, he noted painful lesions on his feet that were white/pale yellow with a central black punctum.
-
In October 2009, the Food and Drug administration (FDA) licensed the bivalent human papillomavirus vaccine (HPV2; Cervarix, GlaxoSmithKline) for use in females aged 10 through 25 years.
-
(Editor's Note: This is the second of a two-part series on geriatrics. This issue, we cover elder stroke patients and ways to make long waits safer. Last month, we covered care of elders with seizures, traumatic brain injuries and psychiatric complaints, and we gave strategies to reduce risks of medication interactions and handoffs.)
-
If you noticed increased lethargy and confusion in your patient, would you suspect an airway problem?